hotel reutemann seegarten

Transcription

Press Tour
64th Lindau Nobel Laureate Meeting on
Physiology or Medicine
29 June–4 July 2014
Press Tour
DENMARK
POLAND
THE
NETHERLANDS
On the occasion of the 64th Lindau Nobel Laureate Meeting on Physiology or Medicine, the
German Academic Exchange Service (DAAD) has invited a group of international journalists
on a one-week press tour through southern Germany. Some 37 Nobel Laureates will meet with
around 600 young researchers from all around the world to share their knowledge, establish
new contacts and exchange ideas.
This year’s Lindau Nobel Laureate Meeting focuses on an issue that is of utmost importance to
every society. Although health research has achieved remarkable advances, there is a constant
need to study and understand biological phenomena and systems and to develop new and
more effective ways to prevent and treat diseases.
HEIDELBERG
6. European Molecular
Biology Laboratory (EMBL)
BELGIUM
TUEBINGEN
2. Natural and Medical
Sciences Institute (NMI),
University of Tübingen / Tissue
Engineering Technologies AG
CZECH
(TETEC) / Retina Implant AG
7. German Cancer Research
Center (DKFZ)
8. Heidelberg Ion Beam
Therapy Center (HIT), Heidelberg University Hospital
REPUBLIC
Heidelberg
FRANCE
Stuttgart
STUTTGART
5. Fraunhofer Institute for
Interfacial Engineering and
Biotechnology (IGB)
Tübingen
3. Hertie Institute for Clinical
Brain Research (HIH) / Werner
Reichardt Centre for Integrative
Neuroscience (CIN), University
of Tübingen
4. Center for Regenerative
Biology and Medicine (ZRM),
University Hospital Tübingen
AUSTRIA
Lindau
LINDAU
1. 64th Lindau Nobel Laureate
Meeting
The main focus of the lectures, panel discussions and master classes is on molecular, genetic
and cellular mechanisms, as they are among the keys to the prevention and healing of diseases.
Some of the topics that will be addressed are the latest findings in cancer research, the advancements made in the fight against HIV/AIDS and the process of ageing at the cellular level and
the diseases associated with that.
The second part of the tour will take the journalists to renowned institutes, universities and companies in the field of medical research in southern Germany. Two of the institutes are celebrating
their anniversaries in 2014: the European Molecular Biology Laboratory (EMBL) was founded
40 years ago, and the German Cancer Research Center (DKFZ) started its activities in 1964.
The press tour is part of the initiative to “Promote Innovation and Research in Germany”, which
the Federal Ministry of Education and Research (BMBF) has launched to strengthen and expand
R&D collaboration between Germany and international partners. Under the brand “Research in
Germany”, the DAAD organises communication activities and events to present German innovation and research in key international markets.
For more information on the Lindau Nobel Laureate Meetings, the DAAD and “Research in
Germany”, visit:
www.lindau-nobel.org
www.daad.de
www.research-in-germany.de
Contents
Programme
Preface
02
Contents
03–13
Programme
14–21
Profiles of Participants (in alphabetical order)
22–23
Lindau Nobel Laureate Meetings
24–47
Profiles of Institutions and Speakers (in order of appearance)
48
49
50–51
52
53
54–55
Service
Organisation (DAAD / Tour Guides / Photographers)
Index of Participants
Index of Institutions
Restaurants
Hotels & Important Telephone Numbers
Notes
56
Imprint
Saturday, 28 June
Individual arrivals from Munich and Zurich
Individual dinner arrangements
Accommodation
Lindau / Lindauer Hof and Hotel Reutemann/Seegarten
Sunday, 29 June
Leisure time
12:15
Walk to restaurant
(Meeting point: lobby of the Lindauer Hof hotel)
12:30–14:00
Official welcome lunch at the restaurant Valentin
hosted by Dr. Birgit Klüsener
Head of Internationalisation of Research Division
German Academic Exchange Service (DAAD)
14:00–14:15
Walk to Inselhalle
15:00–16:30
Opening Ceremony of the 64th Lindau Nobel
Laureate Meeting
(Location: Inselhalle)
Welcome
Countess Bettina Bernadotte
President of the Council
Welcome address
Klas Kärre
Chairperson of The Nobel Assembly Physiology
and Medicine at Karolinska Institutet
Welcome address
Prof. Dr. Johanna Wanka
Federal Minister of Education and Research, Germany
Programme
01
02 | 03
Sunday, 29 June
11:00–11:30
Meeting with DAAD scholarship holders
Dr. Birgit Klüsener
Head of Internationalisation of Research Division
(Meeting point: in front of Inselhalle)
12:30–13:00
Group interview with Nobel Laureate Prof. Bruce A. Beutler
University of Texas Southwestern (2011)
(Location:
)
13:30–13:45
Walk to restaurant
13:45–15:00
Lunch at the restaurant Wissinger’s
15:00–15:15
Walk to Inselhalle
Launch of the Science TV Channel ARD Alpha
The IGNORANCE Study
Prof. Dr. Hans Rosling
Karolinska Institutet, Sweden
Leisure time
17:30–17:45
Walk to the lakeside quay
(Meeting point: lobby of the Lindauer Hof hotel)
18:00–18:52
Boat trip from Lindau to Bregenz and back
(Location: Lindau Harbour)
19:00–19:15
Walk to restaurant
19:15–20:45
Dinner at the restaurant Mole 3
64th Lindau Nobel Laureate Meeting
(For more details, please see the official and individual
programmes.)
19:15–19:30
Walk to Inselhalle
19:30
International Get-Together & Dinner
upon invitation of Australia
(Location: Inselhalle)
Individual return to hotels
Accommodation Lindau / Lindauer Hof and Hotel Reutemann/Seegarten
Accommodation
Lindau / Lindauer Hof and Hotel Reutemann/Seegarten
Monday, 30 June
programmes.)
10:00–10:30
Group interview with Nobel Laureate
Prof. Dr. Rolf Martin Zinkernagel
Universitätsspital Zürich (1996)
(Location:
)
Tuesday, 1 July
programmes.)
Programme
Introduction of the New Member to the Honorary Senate
of the Foundation Lindau Nobel Laureate Meetings
Hansjörg Wyss
Chairman, Wyss Foundation, Switzerland
04 | 05
Tuesday, 1 July
Prof. Dr. Françoise Barré-Sinoussi
Regulation of Retroviral Infections Unit, Virology Department,
Institut Pasteur (2008)
(Location:
)
14:00–14:15
Walk to restaurant
14:15–15:15
Lunch at the restaurant Gasthof Stift
15:15–15:30
Walk to Inselhalle
programmes.)
17:30–18:00
Prof. Dr. Harald zur Hausen
German Cancer Research Center Heidelberg (DKFZ, 2008)
(Location:
)
18:00–18:15
Walk to Stadtmuseum
18:15–19:45
Media gathering
(Location: Stadtmuseum)
19:45–20:00
Walk to Toskanapark
20:00
Grill & Chill: Connecting Cultures
upon invitation of the Council & Foundation,
along with the citizens of Lindau
(Location: Toskanapark)
Accommodation Lindau / Lindauer Hof and Hotel Reutemann/Seegarten
Wednesday, 2 July
Check-out
7:30–10:30
Transfer to Tübingen/Reutlingen (200 km)
Natural and Medical Sciences Institute (NMI),
University of Tübingen
10:30–10:40
Welcome address and introduction
Prof. Dr. Elke Guenther
Head of Cell Biology
10:40–11:10
Improving Drug Safety with Organ-on-Chip Technology
Dr. Julia Schütte
Scientist and Project Leader
11:10–11:35
Tissue Engineering
Dr. Nicolas Lembert
Head of Production (AMG), Quality Management
Tissue Engineering Technologies AG (TETEC)
11:40–12:05
Restoration of Vision: A Camera Chip in the Eye
Dr. Walter-G. Wrobel
President & CEO
Retina Implant AG
12:05–12:35
Nano- and Chromobodies to Target and Trace Antigens
in Living Cells
Prof. Dr. Ulrich Rothbauer
Joint Professorship Pharmaceutical Biotechnology
12:35–12:45
Walk to canteen
12:45–13:45
Lunch at NMI canteen
13:45–14:30
Transfer (10 km)
Programme
13:30–14:00
06 | 07
Wednesday, 2 July
Hertie Institute for Clinical Brain Research (HIH)
Werner Reichardt Centre for Integrative Neuroscience
(CIN), University of Tübingen
Seeds of Dementia: Alzheimer’s Begins Decades
Before Clinical Symptoms Appear
Prof. Dr. Mathias Jucker
Director, Hertie Institute for Clinical Brain Research (HIH),
Vice Speaker of the German Center for Neurodegenerative
Diseases
Influence of Behavioral Contexts on Sensory Visual
Processing
Dr. Laura Busse
Junior Research Group Leader
Werner Reichardt Centre for Integrative Neuroscience (CIN),
Dr. Steffen Katzner
Group Leader, Neural Basis of Visual Behavior
Check-in
19:15–19:30
Walk to restaurant
19:30–21:00
Dinner at the restaurant Gasthausbrauerei Neckarmüller
Individual return to hotel
Accommodation
Thursday, 3 July
Check-out
9:00–9:30
Transfer
9:30–12:30
Center for Regenerative Biology and Medicine (ZRM),
Regenerative Medicine: A Focus on New Therapies
Prof. Dr. Konrad Kohler
Head of the Center for Regenerative Biology
and Medicine (ZRM)
Principles of High-Level Vision: Ego-Motion Perception,
Grouping, and Predictive Coding
Andreas Bartels, PhD
Group Leader, Vision and Cognition Lab
Parkinson’s Disease as a Challenge for Our Aging
Population – What Do We Know, Where Do We Go?
Prof. Dr. Daniela Berg
Group Leader
Hertie Institute for Clinical Brain Research (HIH),
German Center for Neurodegenerative Diseases
17:30–18:00
Transfer to hotel
Tübingen / Hotel Krone
Roboting in Surgery
Prof. Dr. Arnulf Stenzl
Medical Director and Head of the Department of Urology,
Mesenchymal Stromal Cells for Regeneration of the
Sphincter Muscle
Prof. Dr. Wilhelm Aicher
Zentrum für Medizinische Forschung (ZMF),
12:30–13:15
Transfer to Stuttgart (50 km)
13:15–14:15
Lunch at the restaurant Römerhof
Programme
14:30–17:30
08 | 09
Thursday, 3 July
10 | 11
Transfer
Friday, 4 July
14:30–17:00
Fraunhofer Institute for Interfacial Engineering
and Biotechnology (IGB)
Check-out
Fraunhofer IGB – R&D for Medicine, Pharmacy,
Chemistry, Environment, and Energy
Dr. Claudia Vorbeck
Press and Public Relations Officer
9:00–9:30
Transfer
9:30–12:00
European Molecular Biology Laboratory (EMBL)
EMBL – 40 Years of Life Science Research
Lena Raditsch
Head of Communications
Guided lab tour with on-site presentations
Automated Manufacturing of 3D Skin Models
in the Tissue Factory
Florian Groeber
Cell and Tissue Engineering Department
Printable 3D Matrices for the Engineering
of Bioartificial Cartilage
Dr. Kirsten Borchers and Dr. Eva Hoch
Interfacial Engineering and Materials Science Department
Immune Receptors – From Sepsis Diagnostics
to Drug Screening
Dr. Anke Burger-Kentischer
Molecular Cell Technologies Group Manager
Molecular Biotechnology Department
17:00–19:00
Structure and Geography of the Human Gut Microbiome
Paul Costea
PhD Student
12:00–12:15
Walk to canteen
12:15–13:15
Lunch at EMBL canteen
13:15–13:30
Transfer / walk to DKFZ
13:30–16:00
German Cancer Research Center (DKFZ)
Welcome and introduction
Dr. Stefanie Seltmann
Head of Press and Public Relations
Transfer to Heidelberg (120 km)
A Risky Connection: Obesity, Metabolic Syndrome,
and Cancer
Prof. Dr. Stephan Herzig
Head of Molecular Metabolic Control Division
Check-in
20:00–21:30
Dinner at the restaurant Grill 16 (at the Marriott hotel)
Cancer Stem Cells – The Root of All Evil?
Prof. Dr. Andreas Trumpp
Head of Stem Cells and Cancer Division
Accommodation Heidelberg / Marriott Hotel
16:00–16:15
Transfer / walk to HIT
Programme
14:15–14:30
Friday, 4 July
16:15–17:45
Heidelberg Ion Beam Therapy Center (HIT),
Heidelberg University Hospital
The Heidelberg Ion Beam Therapy Center – Five Years of
Experience with a Worldwide Unique Technical Device
in Cancer Treatment
Prof. Dr. Thomas Haberer
Chief Technical Officer
17:45–18:00
Transfer to restaurant
18:00–20:30
Farewell dinner at the restaurant
Kulturbrauerei Heidelberg
20:30–21:30
Transfer to Frankfurt (90 km)
Check-in
Accommodation Frankfurt / InterCityHotel Frankfurt City
Saturday, 5 July
Individual departures
Participants
14 | 15
Claudia Renée ADRIEN | United States
Dr. Katrina (Kat) AUSTEN | United Kingdom
“
Global transportation, agriculture and climate change
can rapidly affect the spread of pathogens. I am interested in
novel vaccines and other preventative tools international research teams create to meet these contemporary challenges.
Education
Current position
BA in journalism with a focus on Latin American studies, University
of Florida (2009)
Freelance journalist for various outlets, including Deutsche Welle;
founder and editor of berlinSCI, a Germany-centric science magazine and blog
I am particularly interested in endocrine-disrupting
pollutants, the Epstein-Barr virus, mental health, nutrition,
internal biosensors and prosthetics.
Education
PhD in chemistry from the Royal Institution and University College
London (2006); MSc in chemistry from UCL (2001)
Current position
Freelance journalist, writer and artist; former CultureLab editor at
New Scientist
Contact
Contact
Mohamed Kassem AHMED | Egypt
Intaek CHAE | Republic of Korea
“
“
I enjoy reporting on medical advances and research
relevant to endemic diseases in third-world countries. I look
forward to learning first-hand about the latest medical developments, especially those that can help treat renal failure and
other diseases common in third-world countries.
Education
Current position
Contact
[email protected]
[email protected]
BA in journalism from the Mass Communication Faculty of Cairo
University (1984)
Managing editor of The Egyptian Gazette, the Middle East’s oldest
English-language daily newspaper, and a writer covering scientific
seminars and medical conferences
I am very interested in stem cell science and technology, particularly with regard to the relationships between life
science, ethics and corresponding policies. I am also eager
to delve into other fields that cross science and technology,
including IT and biotechnology.
Education
Current position
MPH from Seoul National University (1991); bachelor’s degree in
pharmacy from Busan National University (1986)
Editorial writer covering science and technology, medical and public
health issues and social welfare; often also writes about cutting-edge
technology in IT and biotechnology as well as investments in these
fields
[email protected]
Contact
[email protected]
Participants
“
16 | 17
Katharine CHILD | South Africa
Sadika HAMID | Indonesia
“
While South Africa is a world leader in HIV research,
I am also interested in other diseases, especially cancer and
cardiovascular disease. I hope this tour will enable me to
learn about the latest medical research around the world. I
would also like to hear about the challenges scientists face.
Education
Current position
Contact
Honours in journalism from the University of the Witswatersrand
(2009); postgraduate diploma in enterprise management from the
University of Cape Town (2007); BA in social science from UCT
(2002)
I am interested in learning about the latest advancements in medicine and how they could change current
approaches to treating diseases. This trip will give me the
opportunity to present correct information and first-hand
accounts on the latest innovations to my readers.
Education
Current position
Health journalist for The Times, South Africa
[email protected]
Ishani DUTTAGUPTA | India
Contact
“
Current position
Contact
Bachelor’s and master’s degrees in English literature from Jadavpur
University, India (1987, 1989)
Senior assistant editor at The Economic Times, New Delhi
Senior editorial staff member covering fields ranging from public
health and rural empowerment to environmental issues for the news
magazine Tempo English
[email protected]
Dr. Paul JANOSITZ | Germany
“
As a science journalist, I’ve always been interested
in topics related to medicine and life sciences. In addition
to genetics and biotechnology, I am especially intrigued by
common diseases such as diabetes, obesity, hypertension,
cardiovascular disorders and Alzheimer’s.
I have interviewed many scientists and entrepreneurs
whose work has contributed to medicine and life sciences. I
hope this tour will offer the chance to interact with researchers
and senior scientists working in these fields, specifically in the
context of India and other emerging economies.
Education
MA in cultural resources management (2009) and BA in French
studies (2002) from Indonesia University
Education
Current position
[email protected]
Contact
Doctoral degree in chemical engineering (1977) and Dipl. Ing.
degree in chemistry (1971) from TU Berlin
Freelance journalist for various newspapers (Der Tagesspiegel,
Gießener Allgemeine, Stuttgarter Zeitung), weekly journals (Jüdische
Allgemeine), online media (Die Zeit) and various magazines
[email protected]
Participants
“
18 | 19
Margit KOSSOBUDZKA | Poland
Andrea OBAID | Chile
“
I’m interested in research related to stem cells, regenerative medicine, new treatments for cancer, genetics, applications of technology to medicine, and new vaccines.
This tour is a chance to get first-hand information about
the direction in which science is heading and what the biggest problems and hopes are. I am very excited to meet such
distinguished personalities from the field and hope to learn
about the most important health issues in other countries.
Education
MSc in biology and microbiology from the University of Warsaw
(1999)
Current position
Journalist at the science and health desk of the Polish daily newspaper Gazeta Wyborcza
Contact
Education
Current position
[email protected]
Contact
Viet Hung NGUYEN | Vietnam
Current position
Contact
Deputy managing editor and head of the education and science
department at Tien Phong Newspaper; covering fields ranging from
politics to medical sciences, healthcare, environmental issues, energy
and education.
[email protected]
[email protected]
“
I hope this tour will provide me with a lot of useful information related to the latest developments in medicine. I’d like
to learn more about Germany’s leading role in the field, as
well as about tropical diseases, flu vaccines, cancer, cardiovascular issues and stem cell technology.
BA in automatic control and measurement from the Hanoi University
of Science and Technology (1990)
Host/editor of the TV show Technoscience (four seasons), science and
technology journalist at CARAS magazine, writer for the environmentally minded blog ”Green Conscience” of the newspaper La Tercera
Marcos PIVETTA | Brazil
“
Education
Master’s degree in scientific communication and medical and environmental issues from Pompeu Fabra University, Spain (2006); degree in
social communication from Universidad Diego Portales, Chile (2002)
I have written several articles about different areas of
medical research, such as neglected tropical diseases, cancer
and stem cell research. This press tour will be a unique opportunity to talk to top German scientists and Nobel Laureates
from these areas.
Education
Current position
Contact
MA in the history of science from the Pontifical Catholic University of
São Paulo; BA in social communication/journalism from the University
of São Paulo (1990); currently completing a PhD
Special editor at Pesquisa FAPESP, a monthly science news publication that belongs to the São Paulo Research Foundation; has been
working for the magazine since 2000
[email protected]
Participants
“
20 | 21
Anna SHATALOVA | Russia
Dr. Laura VARGAS-PARADA | Mexico
“
The fight against cancer, infections and heart disease
is uniting people all over the world. While Russia has strong
scientific traditions in the medical sphere, the country needs
more information about the latest medical research from
around the globe. I hope this tour will offer such knowledge.
Education
Current position
Contact
Certified specialist in comparative linguistics and foreign literature,
Moscow State University (2008); completed the “Developing Intercultural Competence” programme at Helsinki University, Finland (2007)
Head of the science department at POISK, a weekly publication for
the Russian scientific community; freelance science/education journalist
With Mexico still learning the best ways to link academia and industry, I am very interested in success stories
about how basic science can translate into new technologies. I also look forward to hearing stories that exemplify
how this can be achieved and the policies behind related
collaborations. I also look forward to networking with the
other science journalists attending the tour.
Education
Current position
[email protected]
Contact
Frederick Andrew SHAW | Canada
“
Current position
Contact
BA in English, politics and economics from Queen’s University,
Canada; four decades of freelance writing and consulting
Freelance feature writer and journalist for Canadian Healthcare
Technology, trade fair consultant, Canadian press chief at MEDICA,
travel writer, former globe-trotting sports reporter
[email protected]
Freelance science writer for various local publications, including El
Economista México, La Crónica de Hoy and Variopinto; also writes
for Nature News and Nature Outlook
[email protected]
Yue “Albert” YUAN | China
“
Healthcare is at a crossroads. We can continue down
the path of increasing costs, longer wait times and consequent patient care – or turn dramatically toward innovation.
We need new procedures, new workflows, new technologies,
new funding, and most of all, disruptive innovations to cure
these ills.
Education
Postgraduate studies in communication science at Open University,
UK (2007); PhD in biomedical research from UNAM, Mexico
(2002); MSc in applied molecular biology of infectious diseases
from LSHTM, UK (1994)
I write a weekly column about health and life science
and have been following the latest developments in these fields
for many years. On the tour, I expect to interview a number of
Nobel Laureates in order to find out what they think they have
accomplished and what they are currently working on.
Education
Current position
Contact
MSc in biology from Arizona State University, USA (1995); BSc
in genetics from Fudan University, China (1990)
Science reporter for San Lian Life Weekly, China
[email protected]
Participants
“
The programme is mainly comprised of lectures, discussion sessions, panels and scientific
master classes. The lectures of the Nobel Laureates, held in the morning, reflect current scientific topics and present relevant fields of research of the present and future. The afternoons
are reserved for discussions between the Laureates and the young scientists.
Unlike conventional scientific conferences, the Lindau Nobel Laureate Meetings leave plenty
of room for inspiration and reflection, for personal encounters and intense talks. Alongside
cutting-edge research, universally important issues like sustainability or the responsibilities of
scientists in and for society are of utmost significance for the meetings.
The Lindau Nobel Laureate Meetings have evolved into international forums for scientific
debates on issues of global importance, and have gained many friends and supporters from
all around the world.
The Lindau Nobel Laureate Meetings have been bringing together the most esteemed international scientists of our times every year since 1951. The meetings focus alternately on medicine
and physiology, physics, chemistry and economic sciences. Each year, Nobel Laureates of
the relevant discipline and approximately 600 young scientists from some 80 countries meet
in Lindau for one week. At the event, they learn from each other, exchange knowledge, ideas
and experience, share their enthusiasm for science and make valuable new contacts. The young
participants are required to pass a multi-step international selection process. They find themselves
at the start of their careers and strive for excellence in their specialist fields.
22 | 23
Institutions & Speakers
24 | 25
Dr. Julia SCHÜTTE
Natural and Medical Sciences Institute (NMI),
www.nmi.de
A member of the Innovation Alliance Baden-Württemberg (Germany), the NMI is involved in
application-oriented research at the interface between the life sciences and material science. Its
interdisciplinary team develops new technologies for companies and public research sponsors
in the areas of pharmaceuticals and biotechnology, biomedical technology and surface and
interface technology.
The NMI manages projects from start to finish, from planning all the way to evaluation. Its portfolio also includes subprojects and individual services, such as consulting, technology assessment,
applications for funding and project planning and coordination. It also offers accredited testing
services.
Scientist and Project Leader
Natural and Medical Sciences Institute (NMI) at the University of Tübingen
Before joining the Natural and Medical Sciences Institute of the
University of Tübingen as a scientist in 2011, Dr. Schütte earned
her doctoral degree at NMI earlier that year with a thesis on
cell-based microsystems. She had previously studied chemistry at
the University of Freiburg (Germany). The subjects of Dr. Schütte’s
research now range from the aforementioned microsystems to polymer surface modification and alternatives to animal experiments.
She works on cell-based microfluidic systems and organ-on-chip
technology with an eye toward their application in drug development and drug safety testing.
[email protected]
Joint Professorship Pharmaceutical Biotechnology
Natural and Medical Sciences Institute (NMI) at the University of Tübingen
Following his initial studies of biology at Ludwig-Maximilians-Universität München (Germany), Prof. Rothbauer went on to earn his
PhD at the university’s Institute for Physiological Chemistry in 2003.
In addition to managing a project involving chromobodies and
heading a junior research group on behalf of the German Federal
Government, he has since worked as managing director of the
biotech firm ChromoTek GmbH. Over the years, Prof. Rothbauer’s
research on chromobodies has covered the generation of fluorescent nanoprobes to visualise cellular processes, a technology he
hopes to adapt for high-content analysis and application in pharmaceutical compound screenings. He has also served as a professor of pharmaceutical biotechnology at the University of Tübingen
since 2011.
[email protected]
Prof. Dr. Ulrich ROTHBAUER
26 | 27
Retina Implant AG
www.tetec-ag.com
www.retina-implant.de
TETEC was founded in 2000 as a spinoff of the NMI and the university trauma hospital in Tübingen. With its current staff of 42 employees, TETEC produces autologous chondrocyte implants
(ACI) for knee cartilage injuries and is attempting to develop a biological regeneration technique
for intervertebral disc and meniscal injuries.
Established in Reutlingen (Germany) in 2003, Retina Implant AG’s mission is to restore vision
to those suffering from retinitis pigmentosa. In doing so, the company’s more specific goals
include helping patients achieve orientation within rooms, regain an 8- to 12-degree field of
vision, and in the best cases, count fingers and recognise faces. So far, nearly 40 patients
have received implants over the course of clinical trials. Some have been able to locate
people and objects and read letters and words.
As a subsidiary of Aesculap AG – which itself is part of B|Braun Melsungen – TETEC explores
options in advanced therapy medicinal products (ATMPs, also known as TEMPs in the United
States). Furthermore, it is the market leader in Germany and one of the major players in Europe
in the field of ACI.
Head of Production (AMG), Quality Management
Dr. Lembert began his academic career in biology at Saarland University before earning his doctoral degree in experimental diabetes research from Umea University (Sweden) in 1996. He then transitioned
to postdoctoral research at the same institution’s Department of Histology and Cell Biology. In 1999, Dr. Lembert moved on to the University
of Tübingen, where he earned his postdoctoral lecture qualification in
pharmacology and toxicology and eventually began working in the
Department of General Surgery. After entering the private sector as a
production manager at Biotissue Technologies GmbH in 2007, he assisted NMI in setting up a test laboratory he would go on to direct until
2013. Dr. Lembert now serves as head of production at TETEC AG.
[email protected]
Dr. Walter-G. WROBEL
President & CEO
Retina Implant AG
Dr. Wrobel has been president and CEO of Retina Implant AG
since 2004. He previously served in similar roles within the Carl
Zeiss group and as R&D director at related companies starting
in the late 1980s. Dr. Wrobel earned an MA from Technische
Universität München (Germany, 1976) and a PhD in physics from
Ludwig-Maximilians-Universität München (1981). He also worked
as a research scientist at the Max Planck Institute for Quantum
Optics (Germany) from 1981 to 1983.
[email protected]
Dr. Nicolas LEMBERT
Retina Implant AG is currently under the management of Dr. Walter-G. Wrobel (CEO),
Reinhard Rubow (CFO), Prof. Dr. Eberhart Zrenner and Prof. Dr. Hugo Haemmerle (both
supervisory board).
28 | 29
Prof. Dr. Mathias JUCKER
www.hih-tuebingen.de
The Hertie Institute for Clinical Brain Research was founded in 2001. In its 13 years of existence,
the institute has grown to comprise more than 350 employees at all levels, from technicians to
PhD students to full professors. Its outstanding achievements include discoveries related to the
molecular, genetic and physiological bases of a number of major neurological diseases.
The institute is home to a total of 28 research groups, 25 of them within the aforementioned areas
and three operating as independent research groups. Moreover, the Hertie Institute for Clinical
Brain Research and University Hospital Tübingen’s Clinical Neurology Department together form
the Center of Neurology, which serves as a basis for excellence in research and patient care.
Director, Hertie Institute for Clinical Brain Research (HIH),
Vice Speaker of the German Center for Neurodegenerative Diseases
Mathias Jucker is a professor of cellular neurology, director of
the Hertie Institute for Clinical Brain Research at the University of
Tübingen, and an affiliated professor and vice speaker of the German Center for Neurodegenerative Diseases. Prof. Jucker studied
neurobiology and earned his PhD in 1988 at the Swiss Federal
Institute of Technology Zurich before working as a research scientist at the National Institute on Aging in Baltimore (USA). He then
returned to Switzerland as an assistant professor (START fellow) at
the University of Basel and was appointed to his current position
in Tübingen in 2003. Jucker’s main areas of research include the
cellular and molecular mechanisms responsible for brain ageing
and Alzheimer’s disease.
[email protected]
Group Leader
Hertie Institute for Clinical Brain Research (HIH), University Hospital
Tübingen, German Center for Neurodegenerative Diseases
Prof. Daniela Berg, MD, is a senior physician in University Hospital
Tübingen’s Department of Neurodegeneration. She directs the outpatient clinic for Parkinsonian syndromes, tremors and restless legs
syndrome and is responsible for coordinating clinical studies as
head of the Ultrasound Lab. The primary aim of her group’s clinical work is to provide individualised and patient-centred therapy.
Her main research interests comprise the detection and validation of risk and biomarkers for the diagnosis and progression of
Parkinson’s disease. In 2013, Prof. Berg became the first female
president of the German Parkinson Society (DPG) and medical
director of the Centre of Outpatient Rehabilitation’s Department of
Neurology in Tübingen.
[email protected]
Prof. Dr. Daniela BERG
30 | 31
Dr. Laura BUSSE
Werner Reichardt Centre for Integrative
Neuroscience (CIN), University of Tübingen
www.cin.uni-tuebingen.de
The Werner Reichardt Centre for Integrative Neuroscience (CIN) is an interdisciplinary institution
at the University of Tübingen that is funded by the German Excellence Initiative. Several faculties
– including the Max Planck Institute for Biological Cybernetics, the Hertie Institute for Clinical
Brain Research and the Fraunhofer Institute for Manufacturing, Engineering, and Automation –
are part of the CIN, whose interdisciplinary concept is further supported by numerous internal
and external partners.
Since its foundation in 2008, the CIN has directly supported the work of over 20 research
groups focused on comprehending how the brain functions on many different levels. It also comprises over 60 additional members working on neuro-scientific topics in Tübingen, who contribute
their efforts to furthering the scientific goals of the CIN.
Junior Research Group Leader
Dr. Laura Busse is the leader of the junior research group “Cortical Circuits of Visual Perception” at the University of Tübingen’s
Centre for Integrative Neuroscience. After studying neurosciences
in Tübingen and receiving her PhD in neurobiology in Göttingen
(Germany), she worked as a postdoctoral researcher in San Francisco (USA) and London (UK). She then established her independent research group in 2010. Dr. Busse’s main areas of research
involve the neural circuits underlying visual perception. Her laboratory combines in-vivo extracellular recordings of neuronal populations and optogenetic tools for causal interference with brain activity in the early visual systems of mice.
[email protected]
Group Leader, Neural Basis of Visual Behavior
Dr. Steffen Katzner studied psychology and neuroscience at the
universities of Wuppertal (Germany), Tübingen and Otago (New
Zealand). He earned his PhD from the University of Göttingen
(Germany) and worked at the German Primate Center. After two
postdoctoral research stays at the Smith-Kettlewell Eye Research
Center in San Francisco (USA) and University College London
(UK), Dr. Katzner joined Tübingen’s Centre for Integrative Neuroscience. In 2011, he was awarded a Starting Independent Research Grant from the European Research Council (ERC). The goal
of Dr. Katzner’s research is to understand cortical circuit functions
and relate activity in cortical circuits to perception and behaviour.
[email protected]
Dr. Steffen KATZNER
CIN
32 | 33
Andreas BARTELS, PhD
Group Leader, Vision and Cognition Lab
Andreas Bartels studied biology in Zurich, completed his diploma thesis in San Diego (USA) on computational modelling of single neurons,
and obtained his PhD in vision science at University College London
(UK) using the non-invasive human neuroimaging technique fMRI. Following postdoctoral positions in the US and at the Max Planck Institute
in Tübingen, he has headed his own research group at the University
of Tübingen since 2009. There, he investigates high-level vision using
the full repertoire of techniques available to human research, including
fMRI, EEG, TMS, psychophysics and transcranial current stimulation.
[email protected]
34 | 35
Prof. Dr. Konrad KOHLER
Center for Regenerative Biology and Medicine
(ZRM), University Hospital Tübingen
www.regmed.uni-tuebingen.de
The Center for Regenerative Biology and Medicine (ZRM) – which counts 17 hospitals and
institutes as its founding members – and the Surgical Training Center are joint facilities of the University Hospital and the School of Medicine at the University of Tübingen. The centres develop
and coordinate projects involving innovative biomedical technologies in surgery, implantation
and regenerative medicine – from basic research to clinical application. Their other key activities include developing new, cell-based therapies, transferring research findings into therapeutic
products and coordinating training and education in the field of biomedicine.
Head of the Center for Regenerative Biology and Medicine (ZRM),
Prof. Dr. Konrad Kohler is a professor of neuroscience and head of
the Center for Regenerative Biology and Medicine at the University of Tübingen. After studying biology, anthropology and human
genetics in Munich (Germany) and receiving his PhD in neurobiology, he became a research scientist and group leader at the Department of Neuroophthalmology and Pathophysiology of Vision
in Tübingen. He was appointed to his current position in 2006.
Prof. Kohler’s main areas of research involve the function and dysfunction of neuronal signal processing in the retina, the biocompatibility of technical implants and the development of organotypic
culture systems for drug and toxicity screening.
[email protected]
Medical Director and Head of the Department of Urology,
University Hospital Tübingen has first-class global expertise in the
field of urologic surgery, and is one of the most renowned centres
for benign and malignant diseases and reconstruction in urology.
Prof. Stenzl is chairman of the Scientific Congress Office of the
European Association of Urology since 2012 and member of various national and international urological associations. He is on the
editorial board of the Journal of Urology, European Journal of Urology, Nature Reviews Urology, Scandinavian Journal of Urology
and Chinese Journal of Urology.
[email protected]
Prof. Dr. Arnulf STENZL
ZRM
36 | 37
Prof. Dr. Wilhelm AICHER
Zentrum für Medizinische Forschung (ZMF),
Prof. Dr. Aicher completed his PhD at the University of Alabama at
Birmingham (USA) and the University Hospital Tübingen (UKT). He
was also a research fellow at the former institution (1987-1992) and
a research project manager at the University of Freiburg (Germany,
1992-1996). In 1996, Prof. Aicher was appointed head of research
in the Department of Orthopaedic Surgery (UKT). He then served
as deputy director of UKT’s Center for Regenerative Medicine from
2006 to 2011. He is now head of the clinical research group in the
Department of Urology. Prof. Aicher’s work is supported mainly by extramural research funding (from the Deutsche Forschungsgemeinschaft
(DFG), the Federal Ministry of Education and Research (BMBF) and
trusts), and he has published more than 200 papers.
[email protected]
38 | 39
Dr. Claudia VORBECK
Fraunhofer Institute for Interfacial Engineering
and Biotechnology (IGB)
www.igb.fraunhofer.de
The Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart is engaged in a broad spectrum of R&D work in the fields of interfacial engineering and materials
science, molecular biotechnology, physical process technology, environmental biotechnology
and bioprocess engineering, and cell and tissue engineering.
Its close cooperation with the Institute of Interfacial Process Engineering and Plasma Technology (IGVP) at the University of Stuttgart facilitates continuity from basic research to application.
Under the joint management of Professor Thomas Hirth, the two institutes concentrate on the
development of products and processes for medicine, pharmacy, chemistry, the environment,
and energy.
Press and Public Relations Officer
Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB)
Claudia Vorbeck studied biology at the universities of Bonn and
Tübingen (both Germany) and graduated with a PhD in microbiology from the University of Stuttgart. After an internship at a
life sciences publishing company, she became a PR officer at the
Fraunhofer Institute for Interfacial Engineering and Biotechnology
(IGB). There, Vorbeck is responsible for the institute’s corporate
communication activities, including press and public relations, brochures on the institute’s research topics, online publishing, and the
coordination of IGB´s trade fair participation.
[email protected]
Cell and Tissue Engineering Department
Florian Groeber studied biology at the University of Würzburg
(Germany). In his diploma thesis at the Fraunhofer Institute for Biomedical Engineering (IBMT), he focused on establishing optimised
biophysical and technological protocols for the cryopreservation
of human embryonic stem cells. In 2009, he started his PhD at the
Fraunhofer Institute for Interfacial Engineering and Biotechnology
(IGB), where he developed a vascularised skin model. Groeber
is currently leading the biological work on the automated production of tissue-engineered skin models and has acquired a solid
reputation in advanced in vitro models and dermatology. He also
coordinates several projects designed to bring together medical
professionals, biologists and engineers.
[email protected]
Florian GROEBER
IGB
40 | 41
Dr. Kirsten BORCHERS
Kirsten Borchers studied biology and physics at the Universities of
Karlsruhe and Berlin (Germany), earning her certification to teach.
She then received her doctoral degree from the University of Stuttgart
for her research on micro-structured coatings based on bio-functionalized nanoparticles providing three-dimensional affinity surfaces for protein detection biochips. Since 2007, Borchers has been a scientist at
the Fraunhofer Institute for Interfacial Engineering and Biotechnology
(IGB). As a senior scientist she supervises R&D work on biofabrication,
mainly focusing on surface biofunctionalization and the development
of biological biomaterials 3D printing applications.
[email protected]
Dr. Anke BURGER-KENTISCHER
Molecular Cell Technologies Group Manager
Molecular Biotechnology Department
Anke Burger-Kentischer studied biology at the University of Hohenheim (Germany) and obtained her PhD at the University of
Tübingen. After a postdoctoral fellowship at Ludwig-MaximiliansUniversität’s Institute of Physiology in Munich, she started her research at the Fraunhofer Institute for Interfacial Engineering and
Biotechnology (IGB), where she has headed the Molecular Cell
Technologies Group since 2006. Her major interests include inflammation and immune mediators, their receptors, and structural
elucidation with a focus on developing and establishing cell-based
testing and screening assays (cell-based test systems), as well as
the recombinant production of pharmaceutical proteins (interferons; TLRs, toll-like receptors; PAMPs).
[email protected]
Eva Hoch studied biological chemistry at the Mannheim University
of Applied Sciences (Germany). She received her diploma in 2009
for her work on functional biomaterials for selective cultivation of human skin cells at the Fraunhofer Institute for Interfacial Engineering and
Biotechnology (IGB). In 2013, she finished her PhD at the University
of Stuttgart’s Institute of Interfacial Process Engineering and Plasma
Technology (IGVP) on the subject of biomaterials for inkjet bioprinting
technology. In her current position as a postdoctoral researcher at the
IGVP, Hoch remains focused on this topic and hopes to generate functional articular cartilage with a biomimetic hierarchic structure through
inkjet printing of the bioinks she has developed.
[email protected]
Dr. Eva HOCH
42 | 43
Lena RADITSCH
YEARS I 1974–2014
www.embl.de
EMBL is Europe’s flagship laboratory for the life sciences, with more than 80 independent groups
covering the full spectrum of molecular biology. EMBL is international, innovative and interdisciplinary: its 1,700 employees hail from many nations and work across five sites, including the
main laboratory in Heidelberg and outstations in Grenoble, Hamburg, Hinxton (at the European
Bioinformatics Institute near Cambridge) and Monterotondo (near Rome).
Founded in 1974, EMBL is an intergovernmental organisation that receives public research funding from its member-states. The cornerstones of EMBL’s mission are its fundamental research in
molecular biology; the training of scientists, students, and visitors at all levels; the vital services it
offers to scientists in its member-states; the development of new instruments and methods in the
life sciences; active engagement in technology transfer activities; and the integration of European
life science research. Around 190 students are enrolled in EMBL’s International PhD Programme.
In addition, the laboratory offers a platform for dialogue with the general public through various
science communication activities, such as lecture series, visitor programmes and the dissemination
of scientific achievements.
Head of Communications
Lena Raditsch heads the communications department at the European Molecular Biology Laboratory (EMBL) in Heidelberg. A molecular biologist with qualifications in media relations, she joined
EMBL in 2006 after more than 10 years of experience in the field
of science communication at research institutes and in industry.
[email protected]
PhD Student
Paul Costea holds an undergraduate degree in computer science
from the Technical University of Cluj-Napoca (Romania) and a
master’s degree in computational and systems biology from the
Royal Institute of Technology in Stockholm (Sweden). He worked
for over five years as a software developer for various companies,
mostly in telecommunications. He started his research career working on cancer omics in the laboratory of Joakim Lundeberg under
the supervision of Pelin Akan at SciLifeLab in Stockholm. Currently,
Costea is a PhD student in the laboratory of Peer Bork at EMBL,
where he is working in metagenomics and trying to decipher the
structure and function of the human gut microbiome.
[email protected]
Paul COSTEA
44 | 45
Prof. Dr. Stephan HERZIG
www.dkfz.de
The German Cancer Research Center (DKFZ) is the largest biomedical research institute in Germany. At DKFZ, more than 1,000 scientists work on investigating how cancer develops, identifying cancer risk factors and finding new strategies to prevent the disease.
In cooperation with Heidelberg University Hospital, DKFZ has established the National Center
for Tumor Diseases (NCT) in Heidelberg, where promising approaches from cancer research
are applied to clinical treatment. A member of the Helmholtz Association of National Research
Centres, the centre receives 90 percent of its funding from the Federal Ministry of Education and
Research (BMBF) and 10 percent from the state of Baden-Württemberg.
Head of Molecular Metabolic Control Division
Prof. Dr. Stephan Herzig has been a full professor and head of the
Joint Research Division of Molecular Metabolic Control at DKFZ
in collaboration with the Center for Molecular Biology of the University of Heidelberg (ZMBH) and Heidelberg University Hospital
since 2009. He studied biology and geography at the University
of Göttingen (Germany). There he also received a doctorate in the
molecular characterisation of transcription factors in pancreatic islet
cells. Prof. Herzig continued his career as a research associate
in Göttingen and then at the Salk Institute for Biological Studies,
La Jolla (USA) from 2000 to 2003. In October 2003 he joined
DKFZ as head of an Emmy Noether junior research group.
[email protected]
Head of Stem Cells and Cancer Division
Prof. Dr. Andreas Trumpp is head of the Division of Stem Cells
and Cancer at DKFZ and the founding director of the Heidelberg
Institute for Stem Cell Technology and Experimental Medicine (HISTEM). After studying biology in Freiburg and performing his dissertation at the European Molecular Biology Laboratory (EMBL)
in Heidelberg, he conducted postdoctoral research with Nobel
Prize winner Prof. J. Michael Bishop in San Francisco (USA). Prof.
Trumpp founded the Genetics and Stem Cell Laboratory at the
Swiss Institute for Experimental Cancer Research (ISREC) in Epalinges in 2000 and was appointed a professor at the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland in 2005 before
moving to Heidelberg in 2008.
[email protected]
Prof. Dr. Andreas TRUMPP
DKFZ
46 | 47
Dr. Stefanie SELTMANN
Head of Press and Public Relations
Dr. Stefanie Seltmann studied biology, chemistry and mathematics at
the University of Heidelberg and went on to earn her PhD at DKFZ
in 1995. She then completed an internship in DKFZ’s public relations
section. From 1996 to 2007, she was a member of the scientific editorial department at the German radio station SWR. Dr. Seltmann was
then appointed head of DKFZ’s public relations department in 2008,
just in time to witness Harald zur Hausen – who served on its scientific board for many years – receive the Nobel Prize in Medicine. In
2010, she was chosen as Research Press Officer of the Year by some
800 scientific and medical journalists.
www.heidelberg-university-hospital.com
Heidelberg University Hospital is one of the largest and most prestigious medical centres in
Germany and Europe at large. Excellent patient care, research and teaching have earned
Heidelberg a reputation as a centre of medicine. HIT is the only centre for heavy ion therapy
in Europe and continues a long tradition in precision radiotherapy, a widely accepted clinical
standard developed in Heidelberg.
[email protected]
Chief Technical Officer
Prof. Dr. Haberer has been serving in a number of capacities for
the past 20 years, the first of which began in the biophysics department of the heavy-ion research institute GSI in 1989. In 1995, he
was appointed director of control and safety system development
for a tumor therapy project at GSI. He was then named technical project director of this endeavour in 1997. Prof. Dr. Haberer
serves as scientific technical director of the Heidelberg Ion Therapy
Center since 2005 and as a professor in the Physics Faculty of Goethe University Frankfurt since 2008. In addition to earning his PhD from
the University of Heidelberg in 1994, Prof. Dr. Haberer was awarded
the Otto-Hahn-Preis by the city of Frankfurt am Main in 2000.
[email protected]
Prof. Dr. Thomas HABERER
Service | Organisation
Index of Participants
Dr. Birgit KLUESENER
Head of Division
Internationalisation of Research
[email protected]
(28 June–1 July)
Dr. Katja LASCH
Head of Section
Research Marketing
[email protected]
(28 June–3 July)
Ruth ANDRÉ
Programme Manager
Research Marketing
[email protected]
(28 June–5 July)
Janina FUSSHOELLER
Programme Officer
Research Marketing
[email protected]
(30 June–5 July)
Tour Guides
Rebecka MICHEL
MICHEL International
Relations & Services
[email protected]
(28 June–5 July)
Sarah HARWARDT
MICHEL International
Relations & Services
[email protected]
(28 June)
Photographers
Volker LANNERT
(2–4 July)
Name
Country
Institution
Page
Claudia Renée ADRIEN
United States
berlinSCI.com, Deutsche Welle
14
Mohamed Kassem AHMED
Egypt
The Egyptian Gazette
14
Dr. Katrina (Kat) AUSTEN
United Kingdom
Freelance
15
Intaek CHAE
Republic of Korea
The JoongAng
15
Katharine CHILD
South Africa
The Times, South Africa
16
Ishani DUTTAGUPTA
India
The Economic Times, New Delhi 16
Sadika HAMID
Indonesia
Tempo English Magazine
17
Dr. Paul JANOSITZ
Germany
Freelance
17
Margit KOSSOBUDZKA
Poland
Gazeta Wyborcza
18
Viet Hung NGUYEN
Vietnam
Tien Phong Newspaper
18
Andrea OBAID
Chile
Channel 13, CARAS magazine
19
Marcos PIVETTA
Brazil
Pesquisa FAPESP Magazine
19
Anna SHATALOVA
Russia
POISK – Russian Scientific
20
Community’s Weekly
Frederick Andrew SHAW
Canada
Canadian Healthcare
20
Technology
Dr. Laura VARGAS-PARADA
Mexico
Freelance, El Economista
21
Yue “Albert” YUAN
China
San Lian Life Weekly
21
Service
Nicole MASKUS-TRIPPEL
(30 June)
48 | 49
Index of Institutions
50 | 51
Page
Institution
Page
64th Lindau Nobel Laureate Meeting on Physiology or Medicine
64. Lindauer Nobelpreisträgertagung
Lennart-Bernadotte-Haus
Alfred-Nobel-Platz 1, 88131 Lindau
T +49 (0)8382 277310
22–23
Center for Regenerative Biology and Medicine (ZRM),
Zentrum für Regenerationsbiologie und Regenerative Medizin (ZRM),
Universitätsklinikum Tübingen
Paul-Ehrlich-Straße 15, 72076 Tübingen
T +49 (0)7071 2985034
www.regmed.uni-tuebingen.de
34–36
Natural and Medical Sciences Institute (NMI), University of Tübingen
Naturwissenschaftliches und Medizinisches Institut (NMI) an der
Universität Tübingen
Markwiesenstraße 55, 72770 Reutlingen
T +49 (0)7121 51530-0
www.nmi.de
24–25
Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik (IGB)
Nobelstraße 12, 70569 Stuttgart
T +49 (0)711 9704401
www.igb.fraunhofer.de
38–41
Aspenhaustraße 18, 72770 Reutlingen
T +49 (0)7121 5148760
www.tetec-ag.de
26
Meyerhofstraße 1, 69117 Heidelberg
T +49 (0)6221 387-0
www.embl.de
42–43
Retina Implant AG
Retina Implant AG
Gerhard-Kindler-Straße 8, 72770 Reutlingen
T +49 (0)7121 36403-0
www.retina-implant.de
27
Deutsches Krebsforschungszentrum (DKFZ)
Im Neuenheimer Feld 280, 69120 Heidelberg
T +49 (0)6221 420
www.dkfz.de
44–46
Hertie-Institut für klinische Hirnforschung (HIH)
Hoppe-Seyler-Straße 3, 72076 Tübingen
T +49 (0)7071 2982049
www.hih-tuebingen.de
28–29
47
Universität Tübingen
Otfried-Müller-Straße 25, 72076 Tübingen
T +49 (0)7071 2989185
www.cin.uni-tuebingen.de
30–32
Heidelberger Ionenstrahl-Therapiezentrum (HIT),
Universitätsklinikum Heidelberg
Im Neuenheimer Feld 672, 69120 Heidelberg
T +49 (0)6221 56-0
www.klinikum.uni-heidelberg.de
Service
Institution
Restaurants
Hotels & Important Numbers
Restaurants
Hotels
SUNDAY, 29 JUNE
12:30–14:00
Restaurant Valentin
In der Grub 28a, 88131 Lindau
T +49 (0)8382 5043740
www.valentin-lindau.de
19:15–20:45
Restaurant Mole 3
Segelhafen 3, 88131 Lindau
T +49 (0)8382 9474414
www.mole3.de
MONDAY, 30 JUNE
13:45–15:00
Restaurant Wissinger‘s
In der Grub 28, 88131 Lindau
T +49 (0)8382 5042742
www.wissingers.de
19:30
International Get-Together & Dinner
(Inselhalle)
20:00
Grill & Chill: Connecting Cultures
(Toskanapark)
19:30–21:00
Gasthausbrauerei Neckarmüller
Gartenstraße 4, 72074 Tübingen
T +49 (0)7071 27848
www.neckarmueller.de
THURSDAY, 3 JULY
13:15–14:15
Restaurant Römerhof
Robert-Leicht-Straße 93, 70563 Stuttgart
T +49 (0)711 68788-0
www.roemerhof-kulinarium.de
20:00–21:30
Restaurant Grill 16
(Heidelberg Marriott Hotel)
FRIDAY, 4 JULY
12:15–13:15
EMBL canteen
18:00–20:30
Kulturbrauerei Heidelberg
Leyergasse 6, 69117 Heidelberg
T +49 (0)6221 502980
www.heidelberger-kulturbrauerei.de
LINDAU (28 JUNE–2 JULY)
Lindauer Hof
Dammgasse 2, 88131 Lindau
T +49 (0)8382 4064
www.lindauerhof.de
Hotel Reutemann/Seegarten
Ludwigstraße 23, 88131 Lindau
T +49 (0)8382 9150
www.reutemann-lindau.de
TUEBINGEN (2–3 JULY)
Hotel Krone Tübingen
Uhlandstraße 1, 72072 Tübingen
T +49 (0)7071 1331-0
www.krone-tuebingen.de
HEIDELBERG (3–4 JULY)
Heidelberg Marriott Hotel
Vangerowstraße 16, 69115 Heidelberg
T +49 (0)6221 908-0
www.marriott.de
FRANKFURT (4–5 JULY)
InterCityHotel Frankfurt City
Poststraße 8, 60329 Frankfurt am Main
T +49 (0)69 27391-0
http://de.intercityhotel.com/Frankfurt
Important Telephone Numbers
Service / Organisation:
+49 (0)163 26 09 26 0
+49 (0)151 12 28 80 58
+49 (0)160 88 37 91 6
+49 (0)160 90 53 38 13
+49 (0)160 90 53 37 81
+49 (0)151 22 64 18 96
+49 (0)171 739 42 19
Rebecka Michel (Tour Guide)
Dr. Birgit Klüsener (DAAD)
Dr. Katja Lasch (DAAD)
Ruth André (DAAD)
Janina Fußhöller (DAAD)
Volker Lannert (Photographer)
Eberhard Scheu (Bus driver)
Emergency:
110 / 112
Police / Fire brigade & ambulance
Taxicab services:
+49 (0)7071 68 88 89
+49 (0)6221 30 20 30
+49 (0)69 73 30 30
Tübingen
Heidelberg
Frankfurt
Service
TUESDAY, 1 JULY
14:15–15:15
Gasthof Stift
Stiftsplatz 1, 88131 Lindau
T +49 (0)8382 9357-0
www.hotel-stift.de
WEDNESDAY, 2 JULY
12:45–13:45
NMI canteen
52 | 53
Notes
Notes
54 | 55
Notes
Service
Imprint
Coordination of the Press Tour and Publisher
Deutscher Akademischer Austauschdienst (DAAD)
German Academic Exchange Service
Kennedyallee 50, 53175 Bonn (Germany)
www.daad.de
Dr. Katja Lasch, Ruth André, Janina Fußhöller
Section 523 – Research Marketing
[email protected]
www.research-in-germany.de
The DAAD is the organisation of German higher
education institutions and their student bodies
devoted to internationalising the academic and
scientific research system. In 2013, the DAAD
provided funding to almost 120,000 German
and foreign academics around the world.
Organisation
MICHEL International Relations & Services
Friedrichstraße 191, 10117 Berlin
www.michel-irs.com
Rebecka Michel
[email protected]
Layout and Typesetting
Nicole Rabe, Grafikbüro GRAFIKRABE
www.grafikrabe.de
Print-run: June 2014 – 200
Printed by: Europrint medien GmbH
© DAAD
This publication was funded by the Federal
Ministry of Education and Research.
Photo Credits
DAAD – Volker Lannert: Cover,
p.13/33/34/37 / Rolf Schultes – Lindau
Nobel Laureate Meetings: p.22 / Christian
Flemming – Lindau Nobel Laureate Meetings:
p.23 / Natural and Medical Sciences Institute
(NMI), University of Tübingen: p.24/25 /
TETEC: p.26 / Retina: p.27 / Hertie Institute for Clinical Brain Research (HIH) – Ingo
Rappers: p.28/29 (Jucker) / Universitätsklinikum Tübingen (UKT): p.29 (Berg) / Werner
Reichardt Centre for Integrative Neuroscience
(CIN), University of Tübingen: p.30/31/32 /
Center for Regenerative Biology and Medicine (ZRM), University Hospital Tübingen:
p.35 (Kohler) / University of Tübingen (Department of Urology): p.35 (Stenzl) / Zentrum
für Medizinische Forschung (ZMF), University
Hospital Tübingen: p.36 / Fraunhofer Institute
for Interfacial Engineering and Biotechnology (IGB): p.38/39/40/41 / European
Molecular Biology Laboratory (EMBL):
p.42/43 / German Cancer Research Center
(DKFZ): p.44/45/46 / Heidelberg Ion
Beam Therapy Center (HIT), Heidelberg
University Hospital: p.47 / German Academic
Exchange Service (DAAD): p.48 (Klüsener,
Lasch, André, Fußhöller) / MICHEL International Relations & Services: p.48 (Michel,
Harwardt) / Nicole Maskus-Trippel: p.48 /
Volker Lannert: p.48

hotel reutemann seegarten

Transcription

Similar documents

Geerings Print Brochure

page1

Workshop on Case Method of Teaching at ICFAI University

Profile - Nupress

Download_file - National Committee of the Medicines and Medical

Call for Presentations

29 April 2016

08 - Rohrbasser - Electrophorese capillaire_projet PHARMELP

TREPSEA 2016 - Institut Teknologi Bandung

details - Jamia Millia Islamia